Fetzima and Revlimid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Fetzima (levomilnacipran hydrochloride) and Revlimid (lenalidomide). Common drug interactions include diarrhoea among females.
The phase IV clinical study analyzes what interactions people have when they take Fetzima and Revlimid. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Fetzima?
Fetzima has active ingredients of levomilnacipran hydrochloride. It is often used in depression. eHealthMe is studying from 2,077 Fetzima users. Check the latest studies of Fetzima.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.
12 people who take Fetzima and Revlimid together, and have interactions are studied.
What are the common drug interactions of Fetzima and Revlimid, by gender? *:
female:
- Diarrhoea
- Thrombosis (formation of a blood clot inside a blood vessel)
- Gastrointestinal infection (infection of stomach and intestine)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Rib fracture
- Throat irritation
- Urinary tract infection
- Burning sensation
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Drug hypersensitivity
male:
n/a
What are the common drug interactions of Fetzima and Revlimid, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
60+:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Pain in extremity
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Drug hypersensitivity
- Pruritus generalised (generalized itching)
- Rash
- Swelling
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Blood urine present
- Cystitis (inflammation of the wall of the bladder)
* Approximation only. Some reports may have incomplete information.
Do you take Fetzima and Revlimid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Fetzima and Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fetzima:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fetzima and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Revlimid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on levomilnacipran hydrochloride and lenalidomide (the active ingredients of Fetzima and Revlimid, respectively), and Fetzima and Revlimid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Xanax cause Muscle Spasms? - a second ago
- Drug interactions of Cytotec and Inderal - a second ago
- Could Colistimethate Sodium cause Acute Kidney Failure? - 2 seconds ago
- Could Tobradex cause Diarrhea? - 3 seconds ago
- Could Tobradex cause Stools - Watery? - 3 seconds ago
- Drug interactions of Nuvigil and Parnate - 3 seconds ago
- Malaria and Eye Movement Disorder - 9 seconds ago
- Drug interactions of Cidofovir and Remeron - 11 seconds ago
- Drug interactions of Revlimid and Quinine - 25 seconds ago
- Could Amlodipine cause Eye Disorder? - 28 seconds ago